Effect of a weight loss program on serum adiponectin and insulin resistance among overweight and obese premenopausal females
Authors:
Open Access
- 1 December 2020
- journal article
- research article
- Published by Springer Nature in Journal of the Egyptian Public Health Association
- Vol. 95 (1) , 1-8
Abstract
Background: Obesity has emerged as a public health crisis in many populations including Egypt. Adipose tissue produces a number of adipokines, one of them is adiponectin which has attracted much attention because of its antidiabetic and antiatherogenic effects. Objective: To determine the effect of a weight loss program on serum adiponectin level and insulin resistance among overweight and obese adult premenopausal females. Study design: A pre-postintervention study was carried out among 95 premenopausal overweight and obese females (body mass index ≥ 25 kg/m2) aged 20 to 40 years at the integrated health clinic affiliated to the High Institute of Public Health, Alexandria, Egypt, from February 2016 to February 2017. All participants underwent a weight loss program based on a reduced calorie balanced diet and advised to increase their physical activity. Dietary instructions and follow-up were done weekly throughout 16 weeks. Blood samples were collected to investigate serum adiponectin level and insulin resistance at the beginning and the end of the intervention. Results: After 16 weeks, a significant decrease in body weight by 9.7% was associated with a significant increase in serum adiponectin from 13.3 ± 4.9 μg/ml to 18.5 ± 5.6 μg/ml. Both fasting insulin and insulin resistance had decreased significantly by 13.6% and 13.7%, respectively. Conclusion: A weight reduction program depending on a reduced calorie diet for 16 weeks was associated with a significant increase in total adiponectin level and reduction in insulin resistance. An emphasis on the importance of keeping normal weight through nutritional education and the promotion of healthy diets is recommended to reduce the risk of occurrence of insulin resistance, type 2 diabetes, and cardiovascular diseases.Keywords
This publication has 33 references indexed in Scilit:
- The Role of Body Mass Index, Insulin, and Adiponectin in the Relation Between Fat Distribution and Bone Mineral DensityCalcified Tissue International, 2009
- An increase in plasma adiponectin multimeric complexes follows hypocaloric diet-induced weight loss in obese and overweight pre-menopausal womenClinical Science, 2007
- Adiponectin modulates inflammatory reactions via calreticulin receptor–dependent clearance of early apoptotic bodiesJournal of Clinical Investigation, 2007
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-upClinical Nutrition, 2006
- Adiponectin and Coronary Heart Disease: The Strong Heart StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Use and Abuse of HOMA ModelingDiabetes Care, 2004
- Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal womenInternational Journal of Obesity, 2003
- Adiponectin - Its Role in Metabolism and BeyondHormone and Metabolic Research, 2002
- AdipoQ Is a Novel Adipose-specific Gene Dysregulated in ObesityJournal of Biological Chemistry, 1996